Ondansetron Injection
Product Images NDC 63323-374

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 63323-374). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ond08 0000 01

FDA Label Image

Ond08 0000 02

FDA Label Image

Ond08 0000 03

NDC 63323-373-00 is the code for Ondansetron Injection, a medication used for intramuscular or intravenous administration. It has a strength of 4 mg per 2 mL, which is equivalent to 2 mg per mL. The typical dose is not specified and requires consultation with the package insert. The presentation of the medication is a single-dose vial, and it is only available with a prescription.*

FDA Label Image

Ond08 0000 04

This is a description of a medication with the NDC number 63323-373-02 that contains Ondansetron, a medication used to prevent nausea and vomiting caused by chemotherapy or after surgery. It is a sterile injection that contains 2mg of ondansetron and other components such as sodium chloride, citric acid, and sodium citrate dihydrate. It can be administered intramuscularly or intravenously as directed by a physician. It should be stored between 2-25°C, protected from light, and unused portions should be discarded. This medication is manufactured by Fresenius Kabi and is only available with a prescription.*

FDA Label Image

Ond08 0000 05

This is a product description for Ondansetron Injection, USP. The product comes in a 20 mL multiple dose vial and contains 40 mg of Ondansetron per 2 mL (2 mg per mL). It is intended for intramuscular or intravenous use and requires a prescription (Rx only). The solution is sterile and contains buffers and preservatives. Storage instructions include maintaining a temperature of 2°C to 25°C (36°F to 77°F) and protecting the product from light. The package insert includes information regarding the usual dosage. The provided text also includes the National Drug Code (NDC) and Lot/Exp numbers for the product.*

FDA Label Image

Ond08 0000 06

This is a description of medication Ondansetron injection, USP, in the amount of 40 mg per 20 mL. It is a sterile injection for intramuscular or intravenous use. The medication contains Ondansetron 2 g, hydrochloride, sodium chloride, citric acid monohydrate, sodium citrate dihydrate, buffers, methylparaben, propylparaben, and water for injection. The package insert should be consulted for dosage information. The medication is stored at 2° to 25°C and the container closure is not made with natural rubber latex.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.